Drägerwerk AG & Co. KGaA (0MT8) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, welcome to the Q3 2025 earnings conference call. I am Matilde, the course call operator. I would like to remind you that all participants will be in listen-only mode, and the conference is being recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and 1 on your telephone. For operator assistance, please press star and 0. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Stefan Träger, CEO. Please go ahead. Yes, good afternoon, and thank you for joining our conference call on our financial results for the first nine months, 2025. I have with me today Gert-Heinz Glesbo, CFO, as well as Tom Fischer and Nikola Sammerschmidt, both investor relations. We would like to take you through the results of the presentation that we made available on our webpage this morning. Following the presentation, we will open the floor to your questions. Let's get started on page five with the business highlights. With a significant increase in orders, noticeable growth in sales and very good earnings, We delivered a strong business performance in the first nine months of 2025. Despite difficult economic conditions, demand for our technology for life rose to around 2.6 billion euros. The last time we had such a high order intake after three quarters was in our record year 2020. Growth was driven by both divisions and only The same is true for net sales, which increased to around 2.3 billion. Earnings before interest and taxes almost reached the prior year level at around 77 million euros, despite the positive one of the effects which supported last year's. As a reminder, last year we had divested a non-core business in the Netherlands and u...